[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_15626 

# __And clinical trial management systems__

## Risks linked to this technology

* [Lack of effective treatment and vaccine](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13322.md)
* [Lack of vaccine or specific drug treatment for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19098.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Vaccination development and distribution](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_66.md)

## This technology is mentioned by

* [Madurai_elavarasan_restructured_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_664.md)
* [Tian_investigation_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_544.md)

